Significant difference in Cmax of Reference drug product [Study As­sess­ment]

posted by Mehul Patel – India, 2021-08-17 12:00 (472 d 13:23 ago) – Posting: # 22520
Views: 1,641

Hi,

Can anybody please tell what may be the probable reasons behind significant (more than 20%) difference in mean Cmax concentration of Reference product of a same batch number in two different studies conducted at same CRO and on the similar kind of population but different sample size?

Is it correct to compare and expect Reference product's behavior same for all repeated studies?

Moreover, Can 6 months old (frozen) samples yield significant different results as compared to freshly analyzed study samples?

Complete thread:

UA Flag
Activity
 Admin contact
22,426 posts in 4,694 threads, 1,600 registered users;
21 visitors (0 registered, 21 guests [including 7 identified bots]).
Forum time: 00:23 CET (Europe/Vienna)

The rise of biometry in this 20th century,
like that of geometry in the 3rd century before Christ,
seems to mark out one of the great ages or critical periods
in the advance of the human understanding.    R.A. Fisher

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5